{"id":561349,"date":"2026-07-08T03:00:00","date_gmt":"2026-07-08T01:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/artificial-intelligence-in-precision-oncology-opportunities-and-challenges\/"},"modified":"2026-07-13T16:34:07","modified_gmt":"2026-07-13T14:34:07","slug":"artificial-intelligence-in-precision-oncology-opportunities-and-challenges","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/artificial-intelligence-in-precision-oncology-opportunities-and-challenges\/","title":{"rendered":"Artificial Intelligence in Precision Oncology\u2014Opportunities and Challenges"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>The 2025 ESMO Congress covered a wide range of translational and clinical topics, with the growing importance of artificial intelligence (AI) in diagnosis, prognosis, and treatment decisions standing out in particular. In his presentation titled \u201cAI in Precision Oncology of Liver Cancer,\u201d Prof. Julien Calderaro (Henri Mondor University Hospital, Cr\u00e9teil) presented the latest findings on the use of AI-based methods in precision oncology for liver cancer and highlighted diagnostic, prognostic, and treatment-related aspects. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fartificial-intelligence-in-precision-oncology-opportunities-and-challenges%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>The 2025 ESMO Congress covered a wide range of translational and clinical topics, with the growing importance of artificial intelligence (AI) in diagnosis, prognosis, and treatment decisions standing out in&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fartificial-intelligence-in-precision-oncology-opportunities-and-challenges%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":561351,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Liver Cancer  ","footnotes":"[{\"content\":\"<em>Hematoxylin-Eosin<\\\/em>\",\"id\":\"52b8f7e5-1191-4371-805e-3cc6837f7e02\"}]","_members_access_role":[],"_members_access_error":""},"category":[11548,11513,11391,11370,11503],"tags":[98192,98224,98212,98222,98184,98215,98188,98210,98211,98189,98220,98213,98228,98208,98206,98186,98197,98202,98218,98229,98185,98232,98217,98207,98221,98187,98201,98225,98199,98230,98194,98182,98200,98196,98193,98183,13550,98198,98204,98195,98227,98216,98219,98205,98231,98223,98190,98214,98203,98233,98191,98226,98209],"powerkit_post_featured":[],"class_list":["post-561349","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-congress-reports","category-gastroenterology-and-hepatology","category-oncology","category-studies","tag-abrs-p-model","tag-abrs-p-model-for-predicting-treatment-response-to-atezolizumab-and-bevacizumab","tag-abrs-p-signature-response-to-treatment","tag-ai-analysis-of-he-sections-to-identify-biological-patterns","tag-ai-in-oncology","tag-ai-models-for-molecular-predictions","tag-ai-models-he-sections","tag-ai-prediction-of-immunological-profiles","tag-ai-predictive-models-for-cholangiocarcinoma","tag-ai-assisted-diagnosis-of-liver-tumors","tag-ai-assisted-reclassification-of-combined-hepatocholangiocarcinomas","tag-ai-assisted-treatment-decisions-for-liver-cancer","tag-ai-based-prediction-of-genetic-alterations-such-as-idh1","tag-ai-based-reclassification-of-chc","tag-ai-supported-precision-oncology-for-liver-cancer","tag-artificial-intelligence-precision-oncology","tag-atezolizumab-bevacizumab-liver-cancer","tag-braf-mutations-and-liver-cancer","tag-challenges-in-ai-implementation-in-oncology","tag-challenges-in-implementing-ai-models-in-routine-clinical-practice","tag-combined-hepatobiliary-cholangiocellular-tumors-chc","tag-cost-requirements-for-ai-models-in-switzerland","tag-cost-structure-of-ai-models-in-pathology","tag-digital-he-analysis-of-liver-cancer","tag-digital-pathology-for-differentiating-between-hcc-and-icca","tag-digital-pathology-liver-cancer","tag-esmo-2025-liver-cancer","tag-fgfr2-and-braf-from-routine-histology","tag-fgfr2-fusions","tag-genomics-and-clinical-data","tag-genomics-of-liver-cancer","tag-hepatocellular-carcinoma-hcc","tag-idh1-mutation-in-liver-cancer","tag-imaging-ai-liver-cancer","tag-immunological-gene-expression-signature","tag-intrahepatic-cholangiocarcinoma-icca","tag-liver-cancer","tag-molecular-markers-for-liver-cancer","tag-molecular-tumor-boards-in-switzerland","tag-multimodal-ai-systems","tag-multimodal-ai-systems-for-integrating-imaging-data","tag-multimodal-data-integration-for-liver-cancer","tag-non-commercial-ai-systems-pathology-and-artificial-intelligence-in-precision-oncology-for-liver-cancer","tag-precision-oncology-switzerland","tag-regulatory-and-economic-barriers-to-ai-supported-pathology","tag-spatial-transcriptomics-for-validating-ai-based-classifications","tag-spatial-transcriptomics-of-liver-cancer","tag-spatial-transcriptomics-validation","tag-spo-switzerland","tag-the-importance-of-academic-ai-models-for-rare-tumors-such-as-liver-cancer","tag-times-immune-assessment-system","tag-times-model-for-spatial-immune-assessment-in-cholangiocarcinomas","tag-times-spatial-immunoassay","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-23 09:09:40","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":561353,"slug":"lintelligence-artificielle-en-oncologie-de-precision-opportunites-et-defis","post_title":"L'intelligence artificielle en oncologie de pr\u00e9cision : opportunit\u00e9s et d\u00e9fis","href":"https:\/\/medizinonline.com\/fr\/lintelligence-artificielle-en-oncologie-de-precision-opportunites-et-defis\/"},"it_IT":{"locale":"it_IT","id":561357,"slug":"lintelligenza-artificiale-nelloncologia-di-precisione-opportunita-e-sfide","post_title":"L'intelligenza artificiale nell'oncologia di precisione: opportunit\u00e0 e sfide","href":"https:\/\/medizinonline.com\/it\/lintelligenza-artificiale-nelloncologia-di-precisione-opportunita-e-sfide\/"},"pt_PT":{"locale":"pt_PT","id":561361,"slug":"a-inteligencia-artificial-na-oncologia-de-precisao-oportunidades-e-desafios","post_title":"A Intelig\u00eancia Artificial na oncologia de precis\u00e3o \u2013 oportunidades e desafios","href":"https:\/\/medizinonline.com\/pt-pt\/a-inteligencia-artificial-na-oncologia-de-precisao-oportunidades-e-desafios\/"},"es_ES":{"locale":"es_ES","id":561365,"slug":"la-inteligencia-artificial-en-la-oncologia-de-precision-oportunidades-y-retos","post_title":"La inteligencia artificial en la oncolog\u00eda de precisi\u00f3n: oportunidades y retos","href":"https:\/\/medizinonline.com\/es\/la-inteligencia-artificial-en-la-oncologia-de-precision-oportunidades-y-retos\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/561349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=561349"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/561349\/revisions"}],"predecessor-version":[{"id":561352,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/561349\/revisions\/561352"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/561351"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=561349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=561349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=561349"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=561349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}